Risk of connective-tissue diseases and other disorders after breast implantation.

PubWeight™: 9.25‹?› | Rank: Top 0.1%

🔗 View Article (PMID 8190133)

Published in N Engl J Med on June 16, 1994

Authors

S E Gabriel1, W M O'Fallon, L T Kurland, C M Beard, J E Woods, L J Melton

Author Affiliations

1: Department of Health Sciences Research, Mayo Clinic, Rochester, Minn. 55905.

Articles citing this

Do breast implants cause systemic disease? Science in the courtroom. N Engl J Med (1994) 2.68

Breast implants and connective-tissue diseases. N Engl J Med (1994) 1.94

Prospective cohort study of breast implants and the risk of connective-tissue diseases. Int J Epidemiol (2010) 1.40

Immunopathologic effects of silicone breast implants. West J Med (1995) 1.39

The estimated frequency of cosmetic breast augmentation among US women, 1963 through 1988. Am J Public Health (1995) 1.29

Silicone breast implants: epidemiological evidence of sequelae. Am J Public Health (1999) 1.25

Epidemiologic studies of environmental agents and systemic autoimmune diseases. Environ Health Perspect (1999) 1.04

Fever, rash, and arthritis in a woman with silicone gel breast implants. West J Med (1997) 0.99

Induction of hypergammaglobulinemia and macrophage activation by silicone gels and oils in female A.SW mice. Clin Diagn Lab Immunol (2000) 0.99

Silicone breast implants and connective tissue disease: no association. Semin Immunopathol (2011) 0.92

Phenotype of lymphocytes associated with the inflammatory reaction to silicone gel breast implants. Clin Diagn Lab Immunol (1996) 0.88

Silicone-selective multishot echo-planar imaging for rapid MRI survey of breast implants. Eur Radiol (2007) 0.87

Health characteristics of postmenopausal women with breast implants. Plast Reconstr Surg (2010) 0.82

Occupational and environmental scleroderma. Systematic review and meta-analysis. Clin Rheumatol (2017) 0.81

Update on breast reconstruction techniques and indications. World J Surg (2012) 0.79

Scleroderma and silicone breast implants. West J Med (1997) 0.78

Breast implants and connective-tissue diseases. N Engl J Med (1994) 0.78

Silicone gel breast implant adverse event reports to the Food and Drug Administration, 1984-1995. Public Health Rep (1998) 0.78

Plastic surgery and the breast: a citation analysis of the literature. Plast Reconstr Surg Glob Open (2014) 0.77

Counterfactual thinking and quality of life among women with silicone breast implants. J Behav Med (2002) 0.77

Clinical Outcome of Immediate Breast Reconstruction Using a Silicone Gel-filled Implant after Nipple-preserving Mastectomy. Breast Cancer (1996) 0.77

The socially constructed breast: breast implants and the medical construction of need. Am J Public Health (1998) 0.77

Incidence of capsular contracture in silicone versus saline cosmetic augmentation mammoplasty: A meta-analysis. Can J Plast Surg (2008) 0.76

Breast implants and connective-tissue diseases. N Engl J Med (1994) 0.75

Risk of connective tissue disease among women with breast implants. Study adds nothing to knowledge of processes of tissue injury induced by silicone. BMJ (1998) 0.75

Breast implants and connective-tissue diseases. N Engl J Med (1994) 0.75

Breast cancer after augmentation mammoplasty with silicone gel-filled implant: a case report. Malays J Med Sci (1999) 0.75

Levels of Evidence in the Plastic Surgery Literature: A Citation Analysis of the Top 50 'Classic' Papers. Arch Plast Surg (2015) 0.75

Silicone breast implants and connective tissue diseases. BMJ (1994) 0.75

Breast implants and connective-tissue diseases. N Engl J Med (1994) 0.75

Breast implants and connective-tissue diseases. N Engl J Med (1994) 0.75

Breast prothesis leakage and malignant changes of the breast. Oman Med J (2009) 0.75

Breast implants and connective-tissue diseases. N Engl J Med (1994) 0.75

Arch Gynecol Obstet (1995) 0.75

Silicone breast implant rupture: a review. Gland Surg (2017) 0.75

Breast implant design. Gland Surg (2017) 0.75

Articles by these authors

Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet (2003) 11.91

The diagnosis of osteoporosis. J Bone Miner Res (1994) 10.90

The patient record in epidemiology. Sci Am (1981) 10.32

Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med (1998) 9.43

Hip fractures in the elderly: a world-wide projection. Osteoporos Int (1992) 9.08

Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology (1997) 8.51

Involutional osteoporosis. N Engl J Med (1986) 8.20

Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med (1999) 7.81

Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med (2000) 7.62

Psychotropic drug use and the risk of hip fracture. N Engl J Med (1987) 7.53

The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int (2007) 6.44

Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia (1993) 6.32

The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone (1995) 5.76

Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int (2005) 5.54

Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med (1990) 5.49

Population-based study of herpes zoster and its sequelae. Medicine (Baltimore) (1982) 5.29

A community-based study of the epidemiology of asthma. Incidence rates, 1964-1983. Am Rev Respir Dis (1992) 5.22

Mortality following inpatient addictions treatment. Role of tobacco use in a community-based cohort. JAMA (1996) 5.17

A meta-analysis of previous fracture and subsequent fracture risk. Bone (2004) 4.92

Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology (1992) 4.84

Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989. J Bone Miner Res (1992) 4.75

Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res (1997) 4.74

Population-based study of survival after osteoporotic fractures. Am J Epidemiol (1993) 4.71

Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology (2007) 4.28

Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J Clin Endocrinol Metab (1998) 4.28

A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res (1998) 4.24

Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med (1992) 4.19

The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology (1993) 4.18

Surgical management of Meckel's diverticulum. An epidemiologic, population-based study. Ann Surg (1994) 4.16

The fine structure of some intraganglionic alterations. Neurofibrillary tangles, granulovacuolar bodies and "rod-like" structures as seen in Guam amyotrophic lateral sclerosis and parkinsonism-dementia complex. J Neuropathol Exp Neurol (1968) 4.14

Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989. Stroke (1996) 4.13

Trauma and multiple sclerosis: a population-based cohort study from Olmsted County, Minnesota. Neurology (1993) 4.04

Potential effect of authorization bias on medical record research. Mayo Clin Proc (1999) 4.01

Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology (1991) 3.90

The prevention and treatment of osteoporosis. N Engl J Med (1992) 3.90

Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA (1995) 3.84

Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy. N Engl J Med (1982) 3.77

The epidemiology of epilepsy in Rochester, Minnesota, 1935 through 1967. Epilepsia (1975) 3.67

Lymphoid neogenesis in rheumatoid synovitis. J Immunol (2001) 3.63

The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982-1991. J Rheumatol (2000) 3.62

Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis. J Clin Invest (1981) 3.60

Carpal tunnel syndrome in Rochester, Minnesota, 1961 to 1980. Neurology (1988) 3.40

Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst (2001) 3.37

Thoracic aortic aneurysms: a population-based study. Surgery (1982) 3.36

Assessment of functional gastrointestinal disease: the bowel disease questionnaire. Mayo Clin Proc (1990) 3.34

Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med (1982) 3.30

Epidemiology of vertebral fractures in women. Am J Epidemiol (1989) 3.27

The incidence, causes, and secular trends of head trauma in Olmsted County, Minnesota, 1935-1974. Neurology (1980) 3.23

Factors prognostic of unprovoked seizures after febrile convulsions. N Engl J Med (1987) 3.21

Perturbation of the T-cell repertoire in patients with unstable angina. Circulation (1999) 3.20

The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence, and mortality. Am J Epidemiol (1980) 3.19

Smoking and fracture risk: a meta-analysis. Osteoporos Int (2004) 3.08

Epidemiology of cervical radiculopathy. A population-based study from Rochester, Minnesota, 1976 through 1990. Brain (1994) 3.07

Incidence of spontaneous pneumothorax in Olmsted County, Minnesota: 1950 to 1974. Am Rev Respir Dis (1979) 3.06

T cell homeostasis in patients with rheumatoid arthritis. Proc Natl Acad Sci U S A (2000) 3.06

Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos Int (2011) 3.04

Familial amyotrophic lateral sclerosis. A subgroup characterized by posterior and spinocerebellar tract involvement and hyaline inclusions in the anterior horn cells. Arch Neurol (1967) 3.04

Prevalence of epilepsy in Rochester, Minnesota: 1940-1980. Epilepsia (1991) 3.02

Plasma cell labeling index and beta 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma. Blood (1993) 2.98

Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. Arthritis Rheum (1999) 2.98

Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. Arch Intern Med (1999) 2.98

Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest (2000) 2.94

Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984. Circulation (1989) 2.94

Epidemiology of fractures of the proximal femur in Rochester, Minnesota. Clin Orthop Relat Res (1981) 2.93

Changes in bone mineral density of the proximal femur and spine with aging. Differences between the postmenopausal and senile osteoporosis syndromes. J Clin Invest (1982) 2.92

Diabetes mellitus: incidence, prevalence, survivorship, and causes of death in Rochester, Minnesota, 1945-1970. Diabetes (1976) 2.89

Risk factors for irritable bowel syndrome: role of analgesics and food sensitivities. Am J Gastroenterol (2000) 2.89

Seizures after head trauma: a population study. Neurology (1980) 2.87

Fractures after rheumatoid arthritis. A population-based study. Arthritis Rheum (1984) 2.85

Fracture incidence in Olmsted County, Minnesota: comparison of urban with rural rates and changes in urban rates over time. Osteoporos Int (1999) 2.83

Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989. Blood (1992) 2.81

Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study. Stroke Prevention: Assessment of Risk in a Community. Mayo Clin Proc (1999) 2.80

Relapsing polychondritis. Survival and predictive role of early disease manifestations. Ann Intern Med (1986) 2.80

Epidemiologic features of humeral fractures. Clin Orthop Relat Res (1982) 2.79

Renal stone epidemiology: a 25-year study in Rochester, Minnesota. Kidney Int (1979) 2.79

Ischemic stroke subtypes : a population-based study of functional outcome, survival, and recurrence. Stroke (2000) 2.78

Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J Virol (2001) 2.78

Mayo Clinic Alzheimer's Disease Patient Registry. Aging (Milano) (1990) 2.77

Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med (2000) 2.77

Risk factors associated with symptoms of gastroesophageal reflux. Am J Med (1999) 2.75

Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA. Osteoporos Int (2008) 2.74

Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int (2008) 2.72